Does Medicare Cover COPD? Treatment, Inhalers, Oxygen & Costs (2026)

Medicare Part B provides extensive coverage for outpatient COPD treatment. This includes visits to your primary care physician and pulmonologist (lung specialist), diagnostic testing, pulmonary rehabilitation, oxygen therapy, and preventive screenings. You pay 20% coinsurance after meeting the annual Part B deductible ($283 in 2026).

Pulmonologist visits: Medicare Part B covers visits to a pulmonologist (lung specialist) when referred by your doctor or when medically necessary. If your pulmonologist accepts Medicare assignment, you pay 20% of the Medicare-approved amount. Finding a pulmonologist who accepts Medicare is straightforward: use the Medicare.gov Physician Compare tool or call 1-800-MEDICARE.

Diagnostic tests: Medicare covers spirometry (breathing tests), chest X-rays, CT scans, arterial blood gas tests, pulse oximetry, and other tests used to diagnose and monitor COPD. These are covered under Part B with standard 20% coinsurance.

Pulmonary rehabilitation: Medicare Part B covers pulmonary rehabilitation programs for COPD patients. These programs include supervised exercise, breathing techniques, education about managing your condition, and psychological support. Medicare covers up to 36 sessions (with physician approval for up to 36 additional sessions). You pay 20% coinsurance per session.

Oxygen therapy: When your doctor prescribes home oxygen, Medicare Part B covers the rental of oxygen equipment (concentrators, tanks, regulators, tubing, masks) for up to 36 months. After 36 months, the supplier must continue providing the equipment and maintenance for an additional 24 months at no cost to you. You pay 20% of the Medicare-approved rental amount during the initial 36 months.

Medicare Part D covers prescription medications for COPD, including rescue inhalers, maintenance inhalers, nebulizer solutions, and oral medications. The specific drugs covered and your cost depend on your plan's formulary (drug list) and which tier the medication is placed on.

Common COPD medications covered by Part D: Rescue inhalers (albuterol/ProAir, Ventolin), maintenance inhalers (Spiriva, Advair/Wixela, Breo Ellipta, Symbicort, Trelegy Ellipta, Anoro Ellipta), nebulizer solutions (ipratropium, budesonide), oral medications (prednisone, roflumilast/Daliresp), and combination therapies.

The $2,000 out-of-pocket cap: Starting in 2025, the Inflation Reduction Act caps total Part D out-of-pocket spending at $2,000 per year. This is a major benefit for COPD patients who often take multiple expensive inhalers. Before this cap, some patients paid $5,000 to $10,000+ annually for their COPD medications. The $2,000 cap applies to all Part D drugs combined, and you can spread payments monthly through the Medicare Prescription Payment Plan.

Tier placement matters: Brand-name inhalers like Trelegy Ellipta or Breo Ellipta are often on Tier 3 or Tier 4, meaning higher copays ($40 to $100+ per fill before reaching the cap). Generic alternatives and preferred brands on lower tiers cost less. Ask your doctor about equally effective medications that may be on a lower tier in your specific Part D plan.

Nebulizer solutions vs. inhalers: If you cannot use a metered-dose inhaler effectively, your doctor may prescribe nebulizer treatments. The nebulizer machine itself is covered under Part B as durable medical equipment, while the nebulizer solutions (medications) are covered under Part D. This split coverage can be confusing but ensures both the device and medications are covered.

Medicare Advantage plans (Part C) must cover everything Original Medicare covers, including all COPD treatments. Most MA plans also include Part D drug coverage (MAPD plans), so your inhalers and COPD medications are covered under the same plan. Additionally, many MA plans offer extra benefits relevant to COPD patients.

Extra benefits for COPD patients: Some Medicare Advantage plans offer fitness programs (like SilverSneakers or gym memberships) that can help maintain lung function, telehealth visits for routine COPD check-ins, transportation to medical appointments, and over-the-counter allowances that may cover items like peak flow meters or saline solutions.

Network considerations: If you have COPD, ensure your pulmonologist and preferred hospital are in-network before choosing a Medicare Advantage plan. HMO plans require referrals to see specialists, while PPO plans allow you to see any pulmonologist (though at higher cost for out-of-network providers). For a chronic condition like COPD requiring ongoing specialist care, network access is critical.

Prior authorization: Some Medicare Advantage plans require prior authorization for certain COPD treatments, particularly pulmonary rehabilitation sessions beyond the initial approval, specific brand-name inhalers, or home oxygen therapy. Ask about prior authorization requirements when comparing plans during the Annual Enrollment Period.

Home oxygen therapy is one of the most important treatments for advanced COPD. Medicare Part B covers oxygen equipment when your doctor documents that your blood oxygen level falls below specific thresholds (typically an arterial PO2 at or below 55 mm Hg, or oxygen saturation at or below 88%).

How oxygen rental works: Medicare rents oxygen equipment from a supplier for 36 months. During this rental period, you pay 20% of the Medicare-approved rental amount (typically $30 to $80 per month depending on the equipment). After 36 months, ownership transfers to you, and the supplier must provide the equipment, maintenance, and servicing for an additional 24 months at no charge.

What is covered: Oxygen concentrators (stationary and portable), compressed gas systems, liquid oxygen systems, tubing, nasal cannulas, masks, regulators, humidifiers, and related supplies. Your doctor's prescription determines which type of system you receive based on your oxygen flow requirements and mobility needs.

Qualifying for oxygen: Your doctor must order an arterial blood gas test or pulse oximetry to document your oxygen levels. The test must show that your oxygen levels meet Medicare's criteria. Your doctor must also provide a Certificate of Medical Necessity (CMN) and a written order specifying the flow rate, frequency of use, and duration. Re-testing may be required after 90 days to confirm ongoing need.